Sarah Whelan, PhD
Science Writer
Sarah joined Technology Networks in 2022 after completing a PhD in cancer biology, where her research focused on the development of colon cancers. In her role as science writer and editor, Sarah covers scientific news and a range of other content types, leading the site's coverage of drug discovery, biopharma and cancer research content.
Got a Question for Sarah Whelan, PhD?
Get in touch using the contact form linked here and we’ll get back to you shortly
Published Content
Total: 277
News
Mediterranean Diet Linked to Lower Mortality for Cancer Survivors, Study Finds
Researchers have found that adhering to the Mediterranean diet – known for being rich in vegetables and whole grains and low in sugar and salt – can reduce the risk of mortality for cancer survivors.
News
New Alzheimer’s Drug Donanemab Approved by FDA
The drug donanemab (also known as Kisunla™) has been approved by the US Food and Drug Administration (FDA) for the treatment of adults with early symptomatic Alzheimer’s disease (AD).
Industry Insight
Semarion Wins SLAS Europe Ignite Award 2024
At SLAS Europe 2024, Technology Networks had the pleasure of speaking with Jeroen Verheyen, CEO of Semarion, to discuss their award-winning work and how technological innovations advance research.
News
How Algae Microrobots Could Tackle Inflammatory Bowel Disease
University of California San Diego (UCSD) researchers have developed algae-based “microrobots” that reduce inflammatory bowel disease (IBD) symptoms in mouse models.
News
Antidiabetic Drug Tirzepatide Could Benefit Sleep Apnea Patients
A new clinical trial suggests that an antidiabetic drug, tirzepatide, could effectively treat obstructive sleep apnea (OSA). These data could pave the way to improved quality of life for people affected by the sleep-related disorder.
Industry Insight
SLAS Europe 2024 New Product Award Winners
Two winners earned the New Product Award at SLAS Europe 2024: SEED Biosciences’ Dispen3D and Cryologyx’s PlateReady™. Technology Networks spoke with CEO of CryoLogyx Tom Congdon to learn more about their award-winning new product.
Industry Insight
What FDA Approval of MDMA Could Mean for the Future of Psychedelic Therapy
To learn more about the FDA's pending decision on MDMA-assisted therapy for PTSD, Technology Networks interviewed Dr. Sam Clark, CEO of Terran Biosciences, who leads one of the industry’s largest psychedelic development programs.
Industry Insight
Tackling Plastic Waste for More Sustainable Science
At SLAS Europe 2024, Technology Networks had the pleasure of speaking with Tim Dillon, market manager (Nordics) at Mettler-Toledo Rainin, to learn about how more sustainable options can be implemented into scientists’ daily workflows.
News
Algae-Based Microbots Deliver Cancer Drugs Directly to Lung Tumors
Combining biology and nanotechnology, researchers have developed algae-based “microbots” to deliver drugs directly to lung tumors in mice – with the approach showing promise for reducing tumor growth and increasing survival.
News
Glowing Dye May Help Surgeons Cut Out Prostate Cancer
A fluorescent dye may provide surgeons with a “second pair of eyes” in surgery, helping to remove prostate cancer tumors without damaging healthy tissue.
Advertisement
